Efficacy of Dulaglutide (DU) as First Injectable Option for Patients with Type 2 Diabetes (T2D): A Post Hoc Pooled Analysis

被引：0
|
作者：
Patel, Hiren
Munir, Kashif M.
Sutherland, Sindee S.
Konig, Manige
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-2303-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2303-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes (T2D)
    Ang, Lynn
    Kidwell, Kelley M.
    Dillon, Brendan
    Reiss, Jacob
    Fang, Fang
    Leone, Virginia
    Mizokami-Stout, Kara
    Pop-Busui, Rodica
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (08)
  • [42] Characteristics and Burden of Macro, Micro, and Normoalbuminuria in Patients with Type 2 Diabetes (T2D)
    Blonde, Lawrence
    Wilk, Alan
    Bogdanov, Alina
    Vasey, Joe
    Kallenbach, Lee
    Durkin, Michael
    DIABETES, 2020, 69
  • [43] Diabetic Kidney Disease (DKD) in UK Patients With Type 2 Diabetes (T2D)
    Ruzafa, Javier Cid
    Paczkowski, Rosirene
    Boye, Kristina S.
    Di Tanna, Gian Luca
    Sheetz, Matthew J.
    Donaldson, Robert
    Breyer, Matthew D.
    Neasham, David
    Voelker, James R.
    DIABETES, 2013, 62 : A397 - A397
  • [44] Attitude towards starting insulin therapy in patients with type 2 diabetes (T2D)
    Lee, Lauren J.
    Zagar, Anthony
    Helbers, Lawrence
    Jezorwski, John E.
    Sun, Peter
    Martin, Sherry
    DIABETES, 2008, 57 : A516 - A516
  • [45] YKL-40 in Patients with type 2 diabetes (T2D) and increasing albuminuria
    Brix, Johanna Maria
    Hoellerl, Florian
    Koppensteiner, Renate
    Schernthaner, Guntram
    Schernthaner, Gerit-Holger
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S5 - S5
  • [46] Efficacy and Safety in Chinese T2D Patients Discontinued from OAM to Once-Weekly Dulaglutide Monotherapy
    Li, Yanbing
    Zhang, Bin
    Liu, Siying
    DIABETES, 2020, 69
  • [47] Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data
    Davies, Michael J.
    Merton, Katherine
    Vijapurkar, Ujjwala
    Yee, Jacqueline
    Qiu, Rong
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [48] Cardiovascular (CV) Safety of Linagliptin in Patients With Type 2 Diabetes (T2D): A Pooled Comprehensive Analysis of Prospectively Adjudicated CV Events in Phase 3 Studies
    Johansen, Odd Erik
    Neubacher, Dietmar
    Seck, Thomas
    Patel, Sanjay
    Woerle, Hans-Juergen
    DIABETES, 2013, 62 : A96 - A96
  • [49] Efficacy and Safety of Saxagliptin as Monotherapy in Patients with Type 2 Diabetes: A Pooled Analysis
    Hirshberg, Boaz
    Bryzinski, Brian
    Xu, John
    Monyak, John
    Iqbal, Nayyar
    DIABETES, 2014, 63 : A610 - A610
  • [50] Efficacy and safety of exenatide once weekly in patients with type 2 diabetes mellitus: a post hoc analysis of pooled data from the DURATION clinical trials
    Ruggles, J.
    Grimm, M.
    Han, J.
    Weaver, C.
    Griffin, P.
    Schulteis, C.
    Dong, H.
    Maggs, D.
    Malloy, J.
    DIABETOLOGIA, 2012, 55 : S329 - S329
12345